Also known as: Abiraterone Acetate
Abiraterone is indicated for:
Men, only Adults (18 years old or older)
Abiraterone is indicated with prednisone or prednisolone for:
For this indication, the medical literature mentions below treatments (click for details):
Men, only Adults (18 years old or older)
Abiraterone is indicated with prednisone or prednisolone for the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mHSPC) in adult men in combination with androgen deprivation therapy (ADT).
For this indication, the medical literature mentions below treatments (click for details):
Active ingredient Abiraterone is contraindicated in the following cases:
There are no data on the clinical safety and efficacy of multiple doses of abiraterone acetate when administered to patients with moderate or severe hepatic impairment (Child-Pugh Class B or C). Abiraterone should not be used in patients with severe hepatic impairment.
Abiraterone is not for use in women and is contraindicated in women who are or may potentially be pregnant.
Abiraterone with prednisone or prednisolone is contraindicated in combination with Ra-223.